Form 4: Danaher Corp Director Feroz Dewan Reports Acquisition of Common Stock and Stock Options

Director Feroz Dewan reports acquisition of 390 shares of common stock and 1,081 stock options in Danaher Corp on May 15, 2024.

Summary

• On May 15, 2024, Feroz Dewan, a director of Danaher Corp, acquired 390 shares of common stock.
• These shares were granted as restricted stock units (RSUs).
• Dewan also acquired 1,081 director stock options (right to buy) with an exercise price of $263.46.
• The stock options are exercisable from May 15, 2024, and expire on May 15, 2034.
• The RSUs vest on the earlier of the first anniversary of the grant date or the date immediately prior to the next annual meeting of Danaher's shareholders.
• The underlying shares from the RSUs are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating standard compensation practices. The acquisition of shares and options by a director is generally a positive sign, but it's not a major event.

Positives

• The acquisition of stock and stock options by a director signals confidence in the company's future performance.

Future Outlook

The document does not contain explicit forward-looking statements, but the grant of stock options and RSUs suggests an expectation of continued service and contribution from the director.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading. They provide insights into the actions of company insiders, such as directors, and their confidence in the company's prospects.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in publicly traded companies like Danaher Corp to align their interests with those of shareholders.
• The vesting schedules and terms of these grants are generally in line with industry standards, often tied to continued service and company performance.
• Comparable companies such as Thermo Fisher Scientific and Abbott Laboratories also utilize stock options and RSUs as part of their director compensation packages.

Stakeholder Impact

• The grant of stock options and RSUs aligns the director's interests with those of shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates